PharmaSource: The External Manufacturing Community 5 Outsourcing Leader tickets left Apply for your pass Days Hours Minutes Essential intelligence for biopharma outsourcing leaders | Trusted by 50,000+ professionals | Subscribe TOP STORIES CDMO News at CPHI 2026: Speed, Integration and US Capacity Read More » TETRAPHARM Appoints Rolf Sass Sørensen as CEO Bio-Techne Expands GMP Manufacturing Capacity for Cell Therapies in the UK Andelyn Biosciences Partners With PQP Group Marvel Biosciences Signs LOI With Novotech CRO for Phase 1 First-in-Human Trial of MB-204 in Australia Olon Expands ADC Platform With New Biologics Capacity in France ABIONYX Pharma and OLON Enter Strategic CER-001 Manufacturing Partnership Alvotech and LOTTE Biologics Sign Long-Term Manufacturing Partnership AstraZeneca Opens 570,000-Square-Foot R&D Center in Cambridge Terumo Launches K-Pack Embrace Active Safety Needle Globally ACG Introduces RecycloPod PP Ultra With Moisture and Oxygen Barriers Charles River Laboratories Launches Apollo Orchestrate for Digital GMP Testing Quantum BioPharma Signs Phase 2 Study Start-Up Agreement With Thermo Fisher’s PPD CRO for First-in-Class MS Candidate Lucid-MS Upperton Unveils New Brand Identity for End-to-End CDMO Ofichem to Acquire Kinentia Biosciences and Expand Into U.S. Market RoslinCT Receives Up to £7.25M Grant for Digital Manufacturing Expansion More news + insights TETRAPHARM Appoints Rolf Sass Sørensen as CEO Bio-Techne Expands GMP Manufacturing Capacity for Cell Therapies in the UK Andelyn Biosciences Partners With PQP Group PODCASTS Container Closure Integrity: 6 Considerations for Evaluating CDMO Capabilities How to Select and Sustain an Early-Stage CDMO Partnership SPOTLIGHT Bridging Studies for AAV Producer Cell Line Adoption [Whitepaper] RESOURCES AI Pilots and Strategic Partnerships: ExM Leaders Basel 2026 Report Resilience, Risk & Relationships – ExM Leaders Report Bridging Studies for AAV Producer Cell Line Adoption [Whitepaper] UPCOMING EVENTS CDMO Live Americas . October 20-21, Boston 2026 MASTERCLASS: De-Risking Technology Transfer in OSD AI + Digital Maturity in Contract Manufacturing 2026 External Manufacturing Leaders Dublin 2026
Marvel Biosciences Signs LOI With Novotech CRO for Phase 1 First-in-Human Trial of MB-204 in Australia
Quantum BioPharma Signs Phase 2 Study Start-Up Agreement With Thermo Fisher’s PPD CRO for First-in-Class MS Candidate Lucid-MS